Restart Life Sciences Corp.
NMLSF
$0.05
-$0.02-33.07%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -112.80K | -153.20K | -147.10K | -570.50K | 100.00 |
| Total Depreciation and Amortization | 300.00 | 300.00 | 300.00 | 300.00 | 400.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 174.50K | 32.50K | 34.90K | 419.30K | -1.10K |
| Change in Net Operating Assets | -295.50K | 63.10K | 55.70K | -13.00K | -7.50K |
| Cash from Operations | -233.50K | -57.30K | -56.10K | -163.90K | -8.10K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 250.00K | -- | -- | -- | 15.00K |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -83.00K | -- |
| Issuance of Common Stock | 1.59M | 0.00 | 0.00 | 550.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.32M | 0.00 | 0.00 | 325.40K | 10.70K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.08M | -57.30K | -56.10K | 161.40K | 2.60K |